Skip to main content
Signal8

Wigzell Hans Lennart Rudolf

SEC insider (Form 3/4/5 filer). CIK 0001492766. Director at Sarepta Therapeutics, Inc. (SRPT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CAMBRIDGE, MA.

Companies Wigzell Hans Lennart Rudolf has filed insider reports for

  • Sarepta Therapeutics, Inc. (SRPT): Director
Wigzell Hans Lennart Rudolf profile photo

Wigzell Hans Lennart Rudolf

CIK: 0001492766

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sarepta Therapeutics, Inc. logo
SRPT

Sarepta Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Jun 4, 2026
    Award
    Direct
    16.9K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Award
    Direct
    2.4K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Dec 12, 2024
    Exercise
    Direct
    10.5K shares at avg. $13.71$144K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Dec 12, 2024
    Sale
    Direct
    10.5K shares at avg. $124.84$1.3M

1-4 of 4